Вестник Витебского государственного медицинского университета (Apr 2023)
The analysis of blood components consumption in the Mogilev region in 2017-2021
Abstract
Objectives. To identify the peculiarities of blood components consumption by hospitals in the Mogilev region during five years and to determine trends in their use in connection with the pandemic of COVID-19 infection. Material and methods. Retrospectively for 2017-2021, the volumes of transfusion of erythrocyte blood components (EBC), fresh frozen plasma (FFP), the number of transfused doses of platelet blood components (PBC), cryoprecipitate (CP) in hospitals throughout the Mogilev region were studied depending on the number of treated patients, the number of bed-days spent by them in the hospital and the number of cases of COVID-19 infection. Also these indicators were analyzed in a single health care institution “Mogilev Regional Clinical Hospital”, in which in 2020-2021 care to patients with COVID-19 infection was provided. Results. Consumption of EBC, FFP and CP in 2017-2019 per 1000 inhabitants of the Mogilev region did not change statistically significantly, there was an increase in the use of PBC in 2019 compared to 2017 (p<0.05). In 2020, there was an increase in the consumption of blood components compared to 2017-2019: EBC by 31.7%, PBC by 35.2%, CP by 35.6% from the level of 2017 (p<0.05). In 2021, there was a statistically significant increase in the consumption of blood components compared to 2017-2019: EBC by 27.2%, FFP by 13.9%, PBC by 37%, CP by 23.1% from the level of 2017 (p<0.05). These changes are likely to be related to the 2020-2021 COVID-19 pandemic, which has led to significant changes in the structure of production and clinical use of blood components. Conclusions. The identified trends require to change the resource capabilities of the regional subjects of the blood service for planning and, if necessary, increasing the procurement of PBC, СP, dry one included, and creating a sufficient donor reserve.
Keywords
